Related Experiment Video
Updated: Apr 19, 2026
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
MicroRNA expression and its clinical implications in Ewing's sarcoma
Zheng Li1, Xin Yu, Jianxiong Shen
1Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Beijing, 100007, China.
Abstract:
Ewing's sarcoma (EWS) is the second most common primary bone cancer, and is a predominant childhood malignant disease. Due to limited understanding of its pathogenesis and frequent occurrence of resistance to conventional types of treatment, its management remains difficult, and mortality is frequent. Development of EWS is a multistep process involving genetic and epigenetic alterations of protein-coding proto-oncogenes and tumour-suppressor genes. MicroRNAs (miRNAs) have recently been discovered as a new category of non-protein coding; small RNA molecules that regulate gene expression at the post-transcriptional level. Substantial numbers of deregulated miRNAs have been documented in EWS and their biological significance has been confirmed in multiple functional experiments. Several studies have confirmed involvement of miRNAs in various steps of EWS pathogenesis, from occurrence to metastasis. Functionally, miRNA dysregulation may promote cell-cycle progression, confer resistance to apoptosis, and enhance invasiveness and metastasis. These miRNAs have opened a novel field in cancer research with potential clinical utilization for screening, diagnosis, prognostics and prediction of response to treatment. Elucidating biological aspects of miRNA dysregulation may help better understand pathogenesis of EWS and promote development of miRNA directed-therapeutics against it.
Insights
MicroRNAs (miRNAs) play a crucial role in the development of Ewing sarcoma (EWS), a rare childhood bone cancer. Understanding miRNA dysregulation offers new therapeutic strategies for EWS treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma (EWS) is a prevalent childhood bone cancer with poor prognosis due to treatment resistance and limited understanding of its pathogenesis.
- EWS development involves complex genetic and epigenetic alterations in key genes.
- MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are increasingly recognized for their role in cancer.
Purpose of the Study:
- To investigate the role of deregulated microRNAs (miRNAs) in the pathogenesis of Ewing sarcoma (EWS).
- To explore the potential of miRNAs as diagnostic, prognostic, and therapeutic targets for EWS.
Main Methods:
- Review of existing literature on miRNA deregulation in EWS.
- Functional experiments confirming the biological significance of miRNAs in EWS pathogenesis.
- Analysis of miRNA involvement in EWS progression, including metastasis.
Main Results:
- Numerous deregulated miRNAs have been identified in EWS.
- miRNA dysregulation is implicated in key steps of EWS development, from initiation to metastasis.
- Dysfunctional miRNAs can promote cell proliferation, inhibit apoptosis, and enhance invasiveness.
Conclusions:
- miRNAs are significantly involved in EWS pathogenesis and progression.
- miRNAs represent a promising area for developing novel diagnostic and therapeutic strategies for EWS.
- Further research into miRNA biology in EWS may lead to targeted therapies and improved patient outcomes.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs